Bio Green Med Solution, Inc. (BGMS)

Market Cap	4.53M -87.5%
Revenue (ttm)	1.53M +10,792.9%
Net Income	-14.23M
EPS	-4.11
Shares Out	5.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108,088
Open	0.8118
Previous Close	0.8348
Day's Range	0.8006 - 0.8500
52-Week Range	0.7303 - 19.8660
Beta	-0.38
Analysts	Hold
Price Target	240.00 (+29,168.29%)
Earnings Date	May 14, 2026

About BGMS

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 12
• Stock Exchange: NASDAQ
• Ticker Symbol: BGMS
• Website: https://bgmsglobal.com

Financial Performance

In 2025, Bio Green Med Solution's revenue was $747,000, an increase of 1637.21% compared to the previous year's $43,000. Losses were -$14.09 million, 25.7% more than in 2024.

Analyst Summary

According to one analyst, the rating for BGMS stock is "Hold" and the 12-month stock price target is $240.0.

Price Target

$240.0

(29,168.29% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jun 16, 2026

Data Sources Report a data error